ReviewMolecular therapy. Nucleic acids2026

CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges.

Boris Kantor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.